학술논문
Safety, Virologic Efficacy, and Pharmacokinetics of CT-P59, a Neutralizing Monoclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Protein: Two Randomized, Placebo-Controlled, Phase I Studies in Healthy Individuals and Patients With Mild SARS-CoV-2 Infection
Document Type
Article
Author
Kim, Jin Yong; Jang, Young Rock; Hong, Jang Hee; Jung, Jin Gyu; Park, Jae-Hyeong; Streinu-Cercel, Adrian; Streinu-Cercel, Anca; Săndulescu, Oana; Lee, Sang Joon; Kim, Sung Hyun; Jung, Na Hyun; Lee, Seul Gi; Park, Jeong Eun; Kim, Min Kyung; Jeon, Da Bee; Lee, Yeo Jin; Kim, Bum Soo; Lee, Yeon Mi; Kim, Yeon-Sook
Source
In Clinical Therapeutics October 2021 43(10):1706-1727
Subject
Language
ISSN
0149-2918